Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
52 week low
|
Expensive Underperformer
447.9500
-9.45
(
-2.07
%)
NSE
Jan 13, 2026
15:31 PM
New 52W Low today
Volume:
1.1M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
29 Feb 2024
52 week low
447.95
-2.07%
SUVEN PHARMACEUTICALS LIMITED
Sell:
Cohance Lifesciences Ltd.
by
Geojit BNP Paribas
Target: 571
Recommendation
Target
Geojit BNP Paribas
Cohance Lifesciences Ltd. is trading below all available SMAs
More from Cohance Lifesciences Ltd.
Recommended
Market closes lower, dragged down by foreign investor outflows and mixed earnings
Trendlyne Marketwatch |
13 Jan 2026, 04:07PM
IPO wave continues as Amagi Media and Five SMEs open for subscription
|
12 Jan 2026
Five Interesting Stocks Today - January 9, 2026
The Baseline |
09 Jan 2026